Abstract:Toll-like receptor 7 (TLR7) senses hepatitis C virus (HCV) infection and drives the host specific innate and adaptive immune response. The aim of this study was to estimate the distributions of TLR7 single nucleotide polymorphisms (SNPs), including rs179019 and rs3853839, as well as the effect of TLR7 gene variants on TLR7 mRNA expression and cytokine production in response to TLR7 agonist in vitro. TLR7 SNP genotyping was performed among a Chinese sample population of 418 patients with persistent HCV infection, 317 patients with HCV spontaneous clearance, and 989 healthy controls. TLR7 mRNA expression and TLR7-specific IFN-α and IL-6 secretion in peripheral blood mononuclear cells, derived from 60 healthy individuals in vitro, were then quantified. We identified the association of TLR7 rs3853839C allele, haplotype CC and haplotype AC (rs179019/rs3853839) with protection against HCV persistence in Chinese females (OR=0.49, 95% CI=0.29-0.81, P=0.01 for rs3853839 GC; OR=0.29, 95% CI=0.11-0.75, P=0.01 for rs3853839 CC; OR=0.51, 95% CI=0.38-0.77, P<0.01 for haplotype CC; OR=0.29, 95% CI=0.10-0.88, P=0.03 for haplotype AC). In addition, the rs3853839 CC genotype among female carriers had significantly low TLR7 mRNA expression (P=0.006 for GG vs. CC, P=0.021 for GC vs. CC), along with decreased IFN-α (P=0.002 for GG vs. CC, P=0.021 for GC vs. CC) and increased antiviral IL-6 production (P=0.002 for GG vs. CC, P=0.030 for GC vs. CC), after treatment with Imiquimod in vitro. The cytokine profile among rs3853839 CC genotype female carriers may indicate a pronounced protective effect against persistent HCV infection. The functional polymorphism of TLR7 rs3853839C allele was found to be sex-specific and associated with protection against HCV persistence among Chinese females, which may be due to specific IFN-α and IL-6 secretion profiles.

Research Advancement of TLR7 in Chronic Hepatitis C

Immune Response of TLRs Mediated Anti-Hepatitis B Virus

Advance in Toll-Like Receptor 7-Mediated Antiviral Innate Immune Responses

Toll-like receptors and hepatitis C virus infection

Research on Toll-like Receptor 7 Agonist in Liver Diseases

Sex-specific association between X-linked Toll-like receptor 7 with the outcomes of hepatitis C virus infection.

Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.

Effects of Toll-Like Receptor 7 in Anti-Infection and Autoimmune Disease

Recent Trends in the Development of Toll-like Receptor 7/8-Targeting Therapeutics.

Combination of Renoportal Anastomosis and Inferior Mesenteric Vein-Portal Anastomosis in Liver Transplantation: A New Portal Reconstruction Technique.

Recent Advances in the Discovery and Development of TLR Ligands As Novel Therapeutics for Chronic HBV and HIV Infections

Association of Toll-Like Receptors Single Nucleotide Polymorphisms with HBV and HCV Infection: Research Status.

Peer Review #1 of "association of Toll-Like Receptors Single Nucleotide Polymorphisms with HBV and HCV Infection: Research Status (V0.3)"

Expression of Constitutive IRF7 in Hepatocytes and Its Anti-Viral Function

Impaired Toll-Like Receptor 3-Mediated Immune Responses from Macrophages of Patients Chronically Infected with Hepatitis C Virus

Progress of research on Toll like receptors and viral infection

Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B

Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells

Toll-like Receptor Dependent Innate Immune Responses by Primary Mouse Hepatocytes and Its Control of HBV Replication

Contribution of Toll-Like Receptors to the Control of Hepatitis B Virus Infection by Initiating Antiviral Innate Responses and Promoting Specific Adaptive Immune Responses

Expressions of TLR7 mRNA and IL-6 in mouse microglial cells after hepatitis C virus infection